Literature DB >> 28340359

Diabetic foot ulcer development risk classifications' validation: A multicentre prospective cohort study.

M Monteiro-Soares1, R Ribas2, C Pereira da Silva2, T Bral2, A Mota2, S Pinheiro Torres2, A Morgado2, R Couceiro2, R Ribeiro2, V Dias3, M Moreira3, P Mourão3, M J Oliveira4, M Madureira5, V Paixão-Dias5, M Dinis-Ribeiro6.   

Abstract

AIMS: To prospectively validate the existing classifications to stratify subjects with diabetes mellitus (DM) by their risk of diabetic foot ulcer (DFU), in high and low risk settings.
METHODS: A prospective multicentre cohort study was conducted, including 446 subjects with DM without active DFU followed in the hospital or primary care setting. Demographic, clinical characterization variables, and those included in the classifications were collected at baseline. Subjects were followed for 1year, until DFU or death.
RESULTS: In our sample, with a mean age of 65years, 52% were male; 32 developed a DFU, 7 required an amputation and 18 died. Differences were found between participants' characteristics and classifications' accuracy according to the setting. The great majority of the variables were associated with higher DFU risk. Globally, classifications were highly and equally valid, positive predictive values (PV) were inferior to 40%, negative PV superior to 90% and area under the receiver operating characteristic curve superior to 0.75. DISCUSSION: All the existing classifications are valid to be applied in high risk clinical context and have a very high capacity to categorize as low risk those subjects that will not develop a DFU. Further research is needed in the primary care setting.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Classifications; Diabetic foot; Foot ulcer; Risk

Mesh:

Year:  2017        PMID: 28340359     DOI: 10.1016/j.diabres.2017.02.034

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Is high level of hemoglobin A1C an indicator for extended period of antibiotherapy in diabetic foot ulcers?

Authors:  Mustafa Dogan; Lutfi Cagatay Onar; Bilgehan Aydin; Seyit Ali Gumustas
Journal:  North Clin Istanb       Date:  2019-02-12

2.  Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data.

Authors:  Fay Crawford; Donald J Nicolson; Aparna E Amanna; Angela Martin; Saket Gupta; Graham P Leese; Robert Heggie; Francesca M Chappell; Heather H McIntosh
Journal:  Diabetologia       Date:  2019-11-27       Impact factor: 10.122

3.  Prognostic models for predicting the risk of foot ulcer or amputation in people with type 2 diabetes: a systematic review and external validation study.

Authors:  Joline W J Beulens; Josan S Yauw; Petra J M Elders; Talitha Feenstra; Ron Herings; Roderick C Slieker; Karel G M Moons; Giel Nijpels; Amber A van der Heijden
Journal:  Diabetologia       Date:  2021-04-27       Impact factor: 10.122

4.  Translation and Cross-Cultural Adaptation of Quality of Life Scale in Patients with Onychomycosis.

Authors:  Vasco Silva-Neves; Ana Caramelo; Paulo Alves; Carla Pais-Vieira; Alexandra Palmer Minton; Ana María Rodríguez-Leboeuf; Miguel Pais-Vieira
Journal:  Int J Environ Res Public Health       Date:  2021-05-28       Impact factor: 3.390

5.  Predicting the risk of future diabetic foot ulcer occurrence: a prospective cohort study of patients with diabetes in Tanzania.

Authors:  Roozbeh Naemi; Nachiappan Chockalingam; Janet K Lutale; Zulfiqarali G Abbas
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.